Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 22,177-22,188 of 23,847
Behavioral study icon
CompletedNCT03262350

The Effects of Yoga on Body Image in College Women

This summary needs review. Please check the official study record and contact the research team for details.

In Newark
Eating disordersBehavioralFrom 18 Years to 26 Years
Countries
United States
Sponsor
University of Delaware
Condition
Eating disorders
Device study icon
UnknownNCT04530942

The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression

This study is comparing Deep brain stimulation(Active) with Active DBS then Sham DBS for people with depression or Deep Brain Stimulation. Participants receive Deep brain stimulation(Active) or Active DBS then Sham DBS and complete study visits and assessments.

In Shanghai
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
China
Sponsor
Ruijin Hospital
Condition
Depression
Drug study icon
TerminatedNCT01874756

Selective Estrogen Receptor Beta Agonist for schizophrenia

This study was terminated in the United States. It is testing selective Estrogen Receptor Beta Agonist for schizophrenia.

In Indianapolis
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Drug study icon
CompletedNCT01191918

AChE Inhibitor Donepezil for Bipolarity

This study is completed. It is testing aChE Inhibitor Donepezil for Bipolarity.

Location not clearly listed
BipolarityDrugFrom 18 Years to 60 Years
Countries
Sponsor
Shanghai Mental Health Center
Condition
Bipolarity
Behavioral study icon
CompletedNCT04967560

ALIC/NAcc-DBS for OCD

This study is completed in China. It is testing ALIC/NAcc-DBS for OCD.

Multiple locations, including Zhengzhou
OCDBehavioralFrom 18 Years to 65 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
OCD
Other study type icon
CompletedNCT00418184

Phosphatidylserine-Omega3 for ADHD

This study is completed in Israel. It is testing Phosphatidylserine-Omega3 for ADHD.

In Petach-Tiqva
ADHDOtherFrom 6 Years to 13 Years
Countries
Israel
Sponsor
Enzymotec
Condition
ADHD
Drug study icon
CompletedNCT02139124

PRC-063 for ADHD

This study is completed in the United States and in Canada. It is testing PRC-063 for ADHD.

Multiple locations, including Los Angeles
ADHDDrugOver 18 Years
Countries
United States, Canada
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Drug study icon
CompletedNCT02142556

Quetiapine XR for schizophrenia

This study is completed in Taiwan. It is testing Quetiapine XR for schizophrenia.

In Taipei
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Tri-Service General Hospital (TSGH)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.